Fort Lee, New Jersey, USA, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Herborium® Group,
Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical
Therapeutics® Company and provider of unique, all botanical
medicines (Botanical Therapeutics®), announced today that its
unique all herbal acne treatment, AcnEase®, will be featured in an
editorial in the UK's most popular health focused publication,
AT HOME MAGAZINE's Ask the Doctor with Dr. Christian
Jessen on February 4th, 2015.
Herborium's Lasting Pleasure® and Lasting
Power® formulas for women and men are also making their market
debut in the same edition. The expected readership is over
1.2million.
The featured articles are followed by a massive social media
publicity campaign targeting over a million unique visitors and
over 1.1million page views per month led by Dr. Jessen, and will
continue for 6 months.
Dr. Christian Jessen, Britain's favorite doctor, is the face of
BAFTA award winning health focused television programs and the most
popular medical public health speaker in the UK. His audience
is affluent and educated, female consumers, with 75% of
this audience commanding an income of more than £100,000 per year,
making this an ideal target market for Herborium' s products.
In addition to mass distribution, Ask The Doctor
is also distributed by specialty distributors such as British Air,
Audi, Marriott and La Fitness, significantly increasing the
audience and reach of the publication.
Acne is the most common skin condition in UK, with the average
customer spending more than £150 a month for treatment.
Herborium's partnership with HUT Group, LLC, the UK's leading
multi-website online retailer of Health and Beauty products, with a
goal of £500,000.00 ($785,000.00) in sales within the coming 18-24
month period, provides additional support for AcnEase® growth in
the UK and Europe.
The global market for sexual health formulas is over $8billion
and the UK together with Germany, are the largest markets for these
products in Europe.
"We are very excited about being chosen by At Home
Magazine and Ask The Doctor with Dr. Christian Jessen
to have our Botanical Therapeutics® featured in the most popular
health media outlets in Great Britain. It is both recognition
of our product and a tremendous marketing opportunity. This
is a big step forward towards exponential growth in the UK and
Europe for AcnEase®and our women's and men's sexual
health products with the potential for millions in sales" commented
Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that
develops, license and markets proprietary, botanical based
medicinal products to consumers and healthcare professionals. The
Company business model focuses on emerging market opportunities
spearheaded by the growth of a new market sector located between
high-cost, high-risk, ethical pharmaceuticals and commoditized
classic nutraceuticals (supplements). The Company uses
clinical validation and a proactive regulatory strategy based on
the FDA Guidance for Industry: Botanical Drug Products
(FDA Guidance 2004) to establish and maintain a
differential advantage. Herborium has secured a pipeline of
botanical ingredients based products in the areas of dermatological
needs, wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants, diabetes, surgical procedures, and other
problems. Herborium Group sells its products in the United States,
the United Kingdom, and continental Europe through a network of
distributors, specialty retailers, and e-commerce. For more
information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains
forward-looking statements with respect to the results of
operations and business of Sunrise Consulting Group, Inc., which
involves risks and uncertainties. The Company's actual future
results could materially differ from those discussed.
The Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of
1995.
CONTACT: Contact Information:
Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com